Segregation is good for patients with cystic fibrosis.
作者信息
Conway Steven
机构信息
Regional Paediatric and Adult Cystic Fibrosis Centres, Childrens' Day Hospital, St James' University Hospital Beckett Street, Leeds LS9 7TF, UK.
出版信息
J R Soc Med. 2008 Jul;101 Suppl 1(Suppl 1):S31-5. doi: 10.1258/jrsm.2008.s18007.
Abstract
摘要
相似文献
1
Segregation is good for patients with cystic fibrosis.
J R Soc Med. 2008 Jul;101 Suppl 1(Suppl 1):S31-5. doi: 10.1258/jrsm.2008.s18007.
2
Infection control in cystic fibrosis: methicillin-resistant Staphylococcus aureus, Pseudomonas aeruginosa and the Burkholderia cepacia complex.
J R Soc Med. 2000;93 Suppl 38(Suppl 38):40-5.
3
Pseudomonas cepacia infection in cystic fibrosis.
Lancet. 1992 Jan 25;339(8787):252. doi: 10.1016/0140-6736(92)90063-9.
4
Burkholderia cepacia: another twist and a further threat.
Thorax. 1998 May;53(5):333-4. doi: 10.1136/thx.53.5.333.
5
Recent advances in cross-infection in cystic fibrosis: Burkholderia cepacia complex, Pseudomonas aeruginosa, MRSA and Pandoraea spp.
J R Soc Med. 2003;96 Suppl 43(Suppl 43):66-72.
6
Pseudomonas cepacia in cystic fibrosis: transmissibility and its implications.
Lancet. 1993 Jul 3;342(8862):3-4.
7
Prospective surveillance for Pseudomonas aeruginosa cross-infection at a cystic fibrosis center.
Am J Respir Crit Care Med. 2005 Feb 1;171(3):257-60. doi: 10.1164/rccm.200404-513OC. Epub 2004 Nov 12.
8
Outcome of Burkholderia (Pseudomonas) cepacia colonisation in children with cystic fibrosis following a hospital outbreak.
Thorax. 1995 Nov;50(11):1194-8. doi: 10.1136/thx.50.11.1194.
9
Distribution and transmission of Pseudomonas aeruginosa and Burkholderia cepacia in a hospital ward.
Pediatr Pulmonol. 1996 Feb;21(2):90-100. doi: 10.1002/(SICI)1099-0496(199602)21:2<90::AID-PPUL5>3.0.CO;2-T.
10
Burkholderia cepacia in cystic fibrosis.
N Engl J Med. 1995 Mar 23;332(12):819-20; author reply 820-1.
引用本文的文献
1
Psychological interventions for improving adherence to inhaled therapies in people with cystic fibrosis.
Cochrane Database Syst Rev. 2023 Mar 29;3(3):CD013766. doi: 10.1002/14651858.CD013766.pub2.
2
Current and Emerging Therapies to Combat Cystic Fibrosis Lung Infections.
Microorganisms. 2021 Sep 3;9(9):1874. doi: 10.3390/microorganisms9091874.
3
The coughing body: etiquettes, techniques, sonographies and spaces.
Biosocieties. 2021;16(2):270-288. doi: 10.1057/s41292-020-00196-3. Epub 2020 Sep 15.
4
Brazilian guidelines for the diagnosis and treatment of cystic fibrosis.
J Bras Pneumol. 2017 May-Jun;43(3):219-245. doi: 10.1590/S1806-37562017000000065.
5
Lung transplantation for cystic fibrosis: results, indications, complications, and controversies.
Semin Respir Crit Care Med. 2015 Apr;36(2):299-320. doi: 10.1055/s-0035-1547347. Epub 2015 Mar 31.
6
Twenty-five-year outbreak of Pseudomonas aeruginosa infecting individuals with cystic fibrosis: identification of the prairie epidemic strain.
J Clin Microbiol. 2014 Apr;52(4):1127-35. doi: 10.1128/JCM.03218-13. Epub 2014 Jan 22.
本文引用的文献
1
Transmission of Pseudomonas aeruginosa in children with cystic fibrosis attending summer camps in The Netherlands.
J Cyst Fibros. 2008 Jan;7(1):30-6. doi: 10.1016/j.jcf.2007.04.002. Epub 2007 May 25.
2
Presence of methicillin resistant Staphylococcus aureus in respiratory cultures from cystic fibrosis patients is associated with lower lung function.
Pediatr Pulmonol. 2007 Jun;42(6):513-8. doi: 10.1002/ppul.20604.
3
Segregation--the perspectives of young patients and their parents.
J Cyst Fibros. 2006 May;5(2):93-9. doi: 10.1016/j.jcf.2005.12.002. Epub 2006 Jan 31.
4
Impact of Burkholderia dolosa on lung function and survival in cystic fibrosis.
Am J Respir Crit Care Med. 2006 Feb 15;173(4):421-5. doi: 10.1164/rccm.200503-344OC. Epub 2005 Nov 4.
5
Environmental contamination with an epidemic strain of Pseudomonas aeruginosa in a Liverpool cystic fibrosis centre, and study of its survival on dry surfaces.
J Hosp Infect. 2005 Feb;59(2):102-7. doi: 10.1016/j.jhin.2004.09.018.
6
Prospective surveillance for Pseudomonas aeruginosa cross-infection at a cystic fibrosis center.
Am J Respir Crit Care Med. 2005 Feb 1;171(3):257-60. doi: 10.1164/rccm.200404-513OC. Epub 2004 Nov 12.
7
Pandoraea bacteremia in a cystic fibrosis patient with associated systemic illness.
Pediatr Infect Dis J. 2004 Sep;23(9):881-2. doi: 10.1097/01.inf.0000136857.74561.3c.
8
Cystic fibrosis patients and families support cross-infection measures.
Eur Respir J. 2004 Sep;24(3):449-52. doi: 10.1183/09031936.04.00066803.
9
Rifampicin and sodium fusidate reduces the frequency of methicillin-resistant Staphylococcus aureus (MRSA) isolation in adults with cystic fibrosis and chronic MRSA infection.
J Hosp Infect. 2004 Mar;56(3):208-14. doi: 10.1016/j.jhin.2003.12.003.
10
Burkholderia pseudomallei: another emerging pathogen in cystic fibrosis.
Thorax. 2003 Dec;58(12):1087-91. doi: 10.1136/thorax.58.12.1087.
Zotero 插件